EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
Portfolio Pulse from
Rosen Law Firm is inviting investors who purchased ESSA Pharma Inc. (NASDAQ: EPIX) securities between December 12, 2023, and October 31, 2024, to join a securities fraud lawsuit. The deadline for lead plaintiff applications is March 25, 2025.
March 06, 2025 | 8:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ESSA Pharma Inc. is facing a securities fraud lawsuit, and investors who purchased shares between December 12, 2023, and October 31, 2024, can join the case. The legal proceedings could impact the company's stock price.
The announcement of a securities fraud lawsuit against ESSA Pharma is likely to negatively impact investor sentiment and the stock price in the short term. Legal issues often lead to uncertainty and potential financial liabilities, which can drive the stock price down.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100